Atrial fibrillation, the most common type of irregular heart rhythm, is estimated to affect more than 12 million U.S. adults by 2030. To improve care for the heart condition, the AHA and Bristol Myers Squibb-Pfizer alliance are rolling out an AFib initiative in phases. The latest phase focuses on pharmacists, “an important but underrepresented voice in AFib care,” the AHA said April 23.
The initiative, which runs through June 2025, will host pharmacists in a roundtable event to find gaps and opportunities in AFib care. The findings will then be shared with thousands of hospitals and outpatient clinics in the U.S.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
